{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:43:00Z","timestamp":1785552180877,"version":"3.56.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jaad.2025.10.138","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:00:21Z","timestamp":1762243221000},"page":"1483-1492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Periorificial dermatitis: Pathophysiology, diagnosis, and management"],"prefix":"10.1016","volume":"94","author":[{"given":"Lorena A.","family":"Acevedo-Fontanez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abizairie","family":"S\u00e1nchez-Feliciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Ershadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Reichenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence F.","family":"Eichenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5467-4102","authenticated-orcid":false,"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.10.138_bib1","series-title":"StatPearls","article-title":"Perioral dermatitis","author":"Tolaymat","year":"2025"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-4632.2009.03860.x","article-title":"Periorificial dermatitis in children: an update and description of a child with striking features","volume":"48","author":"Kihiczak","year":"2009","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.10.138_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jaad.2006.05.031","article-title":"Periorificial dermatitis in children and adolescents","volume":"55","author":"Nguyen","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jaad.2025.04.061","article-title":"Validating optimal International Classification of Diseases-10 classification approaches for identifying perioral dermatitis: a retrospective chart review","volume":"93","author":"Ershadi","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jdv.17817","article-title":"Pharmacological interventions for periorificial (perioral) dermatitis in children and adults: a systematic review","volume":"36","author":"Gray","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2025.10.138_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clindermatol.2013.05.034","article-title":"Perioral dermatitis","volume":"32","author":"Lipozen\u010di\u0107","year":"2014","journal-title":"Clin Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.10.138_bib7","first-page":"1025","article-title":"Perioral dermatitis: an uncommon condition?","volume":"134","author":"Hogan","year":"1986","journal-title":"CMAJ"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1085-5629(99)80018-2","article-title":"Perioral dermatitis in children","volume":"18","author":"Laude","year":"1999","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.jaad.2025.10.138_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaad.2008.03.043","article-title":"A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis","volume":"59","author":"Schwarz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.10.138_bib10","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/jocd.13175","article-title":"Efficacy of a skin care cream with TRPV1 inhibitor 4-t-butylcyclohexanol in the topical therapy of perioral dermatitis","volume":"19","author":"Srour","year":"2020","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.10.138_bib11","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jaad.2020.01.064","article-title":"Topical calcineurin inhibitors for pediatric periorificial dermatitis","volume":"82","author":"Ollech","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.10.138_bib12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2133.2004.05985.x","article-title":"Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis","volume":"150","author":"Dirschka","year":"2004","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.10.138_bib13","first-page":"561","article-title":"Rosacea and perioral dermatitis: a single-center retrospective analysis of the clinical presentation of 1032 patients","volume":"18","author":"Hoepfner","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"issue":"9","key":"10.1016\/j.jaad.2025.10.138_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1468-3083.2007.02191.x","article-title":"Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients","volume":"21","author":"Oppel","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2025.10.138_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2230.2003.01349.x","article-title":"Differences between intrafollicular microorganism profiles in perioral and seborrhoeic dermatitis","volume":"28","author":"Takiwaki","year":"2003","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.10.138_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/09546634.2012.757284","article-title":"Three cases of perioral dermatitis related to fusobacteria treated with \u03b2-lactam antibiotics","volume":"25","author":"Ishiguro","year":"2014","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"10.1016\/j.jaad.2025.10.138_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1346-8138.2004.tb00567.x","article-title":"The clinical importance of demodex folliculorum presenting with nonspecific facial signs and symptoms","volume":"31","author":"Karincaoglu","year":"2004","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/exd.70084","article-title":"Comparative analysis of the skin microbiota of rosacea, steroid-induced rosacea and perioral dermatitis","volume":"34","author":"Mochizuki","year":"2025","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2025.10.138_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fimmu.2012.00411","article-title":"The granuloma in tuberculosis: dynamics of a host\u2013pathogen collusion","volume":"3","author":"Ehlers","year":"2013","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jaad.2025.10.138_bib20","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1128\/JCM.00386-12","article-title":"Corynebacterium tuberculostearicum: a potentially misidentified and multiresistant Corynebacterium species isolated from clinical specimens","volume":"50","author":"Hini\u0107","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2025.10.138_bib21","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.5021\/ad.2019.31.S.S27","article-title":"Perioral dermatitis successfully treated with topical ivermectin","volume":"31","author":"Charnowski","year":"2019","journal-title":"Ann Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.10.138_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.10.138_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2133.1972.tb07416.x","article-title":"Perioral dermatitis: aetiology and treatment with tetracycline","volume":"87","author":"Macdonald","year":"1972","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.10.138_bib24","first-page":"701","article-title":"Physical sunscreens with high sun protection factor may cause perioral dermatitis in children","volume":"7","author":"Abeck","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2025.10.138_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1440-0960.1971.tb00003.x","article-title":"Effect of oral inhibitors of ovulation in treatment of rosacea and dermatitis perioralis in women","volume":"12","author":"Spirov","year":"1971","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2340\/00015555-0044","article-title":"Scoring of skin lesions with the perioral dermatitis severity index (PODSI)","volume":"86","author":"Wollenberg","year":"2006","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2013a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2025.10.138_bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1365-4362.2003.01852.x","article-title":"Perioral dermatitis: an update","volume":"42","author":"Hafeez","year":"2003","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.10.138_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.clindermatol.2010.03.006","article-title":"Demodex mites: facts and controversies","volume":"28","author":"Elston","year":"2010","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib30","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5021\/ad.2011.23.3.386","article-title":"Childhood granulomatous periorificial dermatitis","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.10.138_bib31","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1111\/1346-8138.16858","article-title":"Dermoscopy in the diagnosis and treatment of childhood granulomatous periorificial dermatitis","volume":"50","author":"Hayakawa","year":"2023","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.10.138_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1468-3083.2006.01820.x","article-title":"Granulomatous periorificial dermatitis in an 11-year-old boy: dramatic response to tacrolimus","volume":"21","author":"Hussain","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2310\/7750.2008.07088","article-title":"Granulomatous periorificial dermatitis: a variant of granulomatous rosacea in children?","volume":"13","author":"Lucas","year":"2009","journal-title":"J Cutan Med Surg"},{"issue":"11","key":"10.1016\/j.jaad.2025.10.138_bib34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1346-8138.2006.00183.x","article-title":"Case of childhood granulomatous periorificial dermatitis in a Korean boy treated by oral erythromycin","volume":"33","author":"Choi","year":"2006","journal-title":"J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2025.10.138_bib35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00105-013-2684-0","article-title":"Lupoid perioral dermatitis as a special form of perioral dermatitis: review of pathogenesis and new therapeutic options. Article in German","volume":"64","author":"Baratli","year":"2013","journal-title":"Hautarzt"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2133.1971.tb14214.x","article-title":"Perioral dermatitis. A histopathologic study of 26 cases","volume":"84","author":"Marks","year":"1971","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.10.138_bib37","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jocd.14315","article-title":"Topical calcineurin inhibitors as a double-edged sword in rosacea: a systematic review","volume":"21","author":"Zhang","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.10.138_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1600-0625.2009.00941.x","article-title":"Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function","volume":"19","author":"Kim","year":"2010","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/09546639309084514","article-title":"A topical erythromycin preparation and oral tetracycline for the treatment of perioral dermatitis: a placebo-controlled trial","volume":"4","author":"Weber","year":"1993","journal-title":"J Dermatol Treat"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0190-9622(91)70038-4","article-title":"Topical metronidazole in the treatment of perioral dermatitis","volume":"24","author":"Veien","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.10.138_bib41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2133.2004.06202.x","article-title":"Azelaic acid as a new treatment for perioral dermatitis: results from an open study","volume":"151","author":"Jansen","year":"2004","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.10.138_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.36849\/JDD.8590","article-title":"A single-center pilot study to evaluate the efficacy, safety, and tolerability of sarecycline for treating periorificial dermatitis","volume":"24","author":"Swenson","year":"2025","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.det.2015.12.003","article-title":"The clinical relevance of antibiotic resistance: thirteen principles that every dermatologist needs to consider when prescribing antibiotic therapy","volume":"34","author":"Del Rosso","year":"2016","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.jaad.2025.10.138_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-4632.2004.02283.x","article-title":"Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide\/clindamycin topical gel in the treatment of patients with moderate to severe rosacea","volume":"43","author":"Breneman","year":"2004","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaad.2016.10.034","article-title":"Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: a series of 15 cases","volume":"76","author":"Noguera-Morel","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib47","article-title":"A double-blind, randomized, vehicle controlled study","volume":"54","author":"Draelos","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.10.138_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00403-025-03890-z","article-title":"Off-label use of JAK1 inhibitor upadacitinib in dermatology","volume":"317","author":"Zhang","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2025.10.138_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdcr.2024.02.022","article-title":"Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream","volume":"47","author":"Tran","year":"2024","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00431-025-05975-3","article-title":"Periorificial dermatitis in infants and preschoolers \u2013 a narrative review","volume":"184","author":"Chiriac","year":"2025","journal-title":"Eur J Pediatr"},{"issue":"11","key":"10.1016\/j.jaad.2025.10.138_bib51","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamadermatol.2024.3121","article-title":"Roflumilast cream, 0.15%, for atopic dermatitis in adults and children: INTEGUMENT-1 and INTEGUMENT-2 randomized clinical trials","volume":"160","author":"Simpson","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.10.138_bib52","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1111\/all.15742","article-title":"Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis","volume":"78","author":"Hartmann","year":"2023","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.jaad.2025.10.138_bib53","doi-asserted-by":"crossref","first-page":"834","DOI":"10.36849\/JDD.7958","article-title":"Assessment of the vehicle for roflumilast cream compared to a ceramide-containing moisturizing cream in mild eczema","volume":"23","author":"Draelos","year":"2024","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib54","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jaad.2018.09.055","article-title":"Approaches to limit systemic antibiotic use in acne: systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments","volume":"80","author":"Barbieri","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib55","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S1473-3099(15)00527-7","article-title":"Systematic review of antibiotic resistance in acne: an increasing topical and oral threat","volume":"16","author":"Walsh","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.jaad.2025.10.138_bib56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.291.7.827","article-title":"Antibiotic use in relation to the risk of breast cancer","volume":"291","author":"Velicer","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40257-014-0067-7","article-title":"Perioral dermatitis: a review of the condition with special attention to treatment options","volume":"15","author":"Tempark","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.10.138_bib58","first-page":"20","volume":"4","author":"Rosso","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.10.138_bib59","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamadermatol.2024.6542","article-title":"Efficacy, safety, and tolerability of oral DFD-29, a low-dose formulation of minocycline, in rosacea: two phase 3 randomized clinical trials","volume":"161","author":"Bhatia","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib60","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.36849\/JDD.7638","article-title":"Sarecycline as a potential treatment for steroid-induced rosacea\/perioral dermatitis: a case report","volume":"23","author":"Sher","year":"2024","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.10.138_bib61","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.jaad.2025.10.138_bib62","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1442-2050.2004.00384.x","article-title":"Doxycycline-induced pill esophagitis","volume":"17","author":"Kadayifci","year":"2004","journal-title":"Dis Esophagus"},{"issue":"4","key":"10.1016\/j.jaad.2025.10.138_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09546639609089553","article-title":"The antimicrobial effects in vivo of minocycline, doxycycline and tetracycline in humans","volume":"7","author":"Leyden","year":"1996","journal-title":"J Dermatol Treat"},{"issue":"1","key":"10.1016\/j.jaad.2025.10.138_bib64","doi-asserted-by":"crossref","first-page":"e01297","DOI":"10.1128\/AAC.01297-18","article-title":"Microbiological profile of sarecycline, a novel targeted spectrum tetracycline for the treatment of acne vulgaris","volume":"63","author":"Zhanel","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.jaad.2025.10.138_bib65","first-page":"987","article-title":"Once-daily oral sarecycline 1.5 mg\/kg\/day is effective for moderate to severe acne vulgaris: results from two identically designed, phase 3, randomized, double-blind clinical trials","volume":"17","author":"Moore","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2025.10.138_bib66","series-title":"Sarecycline package insert","year":"2018"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/pde.12534","article-title":"Pediatric periorificial dermatitis: clinical course and treatment outcomes in 222 patients","volume":"32","author":"Goel","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.10.138_bib68","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/archderm.138.10.1354","article-title":"Extrafacial and generalized granulomatous periorificial dermatitis","volume":"138","author":"Urbatsch","year":"2002","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib70","article-title":"Ivermectin: a multifaceted drug with a potential beyond anti-parasitic therapy","volume":"16","author":"Kaur","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.jaad.2025.10.138_bib71","first-page":"413","article-title":"Perioral dermatitis with histopathologic features of granulomatous rosacea: successful treatment with isotretinoin","volume":"46","author":"Smith","year":"1990","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.jaad.2025.10.138_bib72","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/pde.13969","article-title":"Recalcitrant granulomatous periorificial dermatitis with good response to low-dose oral isotretinoin","volume":"36","author":"Rodriguez-Garijo","year":"2019","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.10.138_bib73","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0536.1990.tb01558.x","article-title":"Perioral dermatitis in a child due to rosin in chewing gum","volume":"22","author":"Satyawan","year":"1990","journal-title":"Contact Dermatitis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222503138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222503138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:09:00Z","timestamp":1776406140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222503138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S019096222503138X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.10.138","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periorificial dermatitis: Pathophysiology, diagnosis, and management","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.10.138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}